Ana Rovira

6.7k total citations · 1 hit paper
133 papers, 4.3k citations indexed

About

Ana Rovira is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ana Rovira has authored 133 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 52 papers in Molecular Biology and 23 papers in Cancer Research. Recurrent topics in Ana Rovira's work include HER2/EGFR in Cancer Research (14 papers), Lung Cancer Research Studies (13 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). Ana Rovira is often cited by papers focused on HER2/EGFR in Cancer Research (14 papers), Lung Cancer Research Studies (13 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). Ana Rovira collaborates with scholars based in Spain, United States and United Kingdom. Ana Rovira's co-authors include Joan Albanell, Federico Rojo, Pere Gascón, Aňa Lluch, Begoña Mellado, Beatríz Bellosillo, Sílvia Menéndez, Sandra Zazo, Ignasi Tusquets and Alba Dalmases and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Ana Rovira

128 papers receiving 4.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer

2012 367 citations Alba Dalmases, Mar Iglesias et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana Rovira Spain	37	2.0k	1.9k	1.1k	767	418	133	4.3k
Anne E. Cress United States	41	2.8k 1.4×	1.8k 0.9×	931 0.8×	924 1.2×	464 1.1×	147	5.4k
Andrew Dodson United Kingdom	34	1.9k 0.9×	1.1k 0.6×	910 0.8×	536 0.7×	338 0.8×	79	3.5k
Elizabeth A. Harrington United States	26	3.2k 1.6×	1.9k 1.0×	710 0.6×	714 0.9×	517 1.2×	69	5.1k
Luigi Strizzi United States	36	3.1k 1.6×	2.2k 1.1×	711 0.6×	1.1k 1.5×	368 0.9×	85	5.1k
Dominic Fan United States	37	2.0k 1.0×	2.0k 1.0×	755 0.7×	861 1.1×	494 1.2×	72	4.1k
John D. Haley United States	34	2.8k 1.4×	1.9k 1.0×	771 0.7×	1.1k 1.5×	200 0.5×	95	4.8k
Sufi M. Thomas United States	43	2.7k 1.3×	2.2k 1.1×	852 0.8×	1.0k 1.3×	486 1.2×	106	5.2k
E. Aubrey Thompson United States	42	3.3k 1.6×	1.6k 0.8×	1.2k 1.1×	486 0.6×	504 1.2×	112	5.0k
Antonio Gualberto United States	35	3.1k 1.5×	1.6k 0.8×	1.3k 1.2×	925 1.2×	590 1.4×	109	5.2k
Hongbo Zhu China	31	2.6k 1.3×	1.1k 0.6×	981 0.9×	501 0.7×	332 0.8×	95	4.3k

Countries citing papers authored by Ana Rovira

Since Specialization

Citations

This map shows the geographic impact of Ana Rovira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Rovira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Rovira more than expected).

Fields of papers citing papers by Ana Rovira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Rovira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Rovira. The network helps show where Ana Rovira may publish in the future.

Co-authorship network of co-authors of Ana Rovira

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Rovira. A scholar is included among the top collaborators of Ana Rovira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Rovira. Ana Rovira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lameirinhas, Ana, Iris Garrido‐Cano, Cristina Hernándo, et al.. (2025). Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer. Molecular Medicine. 31(1). 116–116.

Rocha, Pedro, Sílvia Menéndez, Ignacio Sánchez, et al.. (2025). The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung Cancer. International Journal of Molecular Sciences. 26(3). 1293–1293. 2 indexed citations

Casadevall, David, Sara García‐Alonso, Sílvia Menéndez, et al.. (2022). mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer. Molecular Cancer Research. 20(7). 1108–1121. 15 indexed citations

Muntasell, Aura, Federico Rojo, Sònia Servitja, et al.. (2019). NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival. Clinical Cancer Research. 25(5). 1535–1545. 89 indexed citations

Rodríguez‐Vida, Alejo, Núria Juanpere, Oriol Arpí, et al.. (2019). Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models. Molecular Cancer Research. 17(9). 1931–1944. 27 indexed citations

Tormo, Eduardo, Sandra Ballester, Anna Adam‐Artigues, et al.. (2019). The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors. Scientific Reports. 9(1). 5316–5316. 71 indexed citations

Tormo, Eduardo, Anna Adam‐Artigues, Sandra Ballester, et al.. (2017). The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene. Scientific Reports. 7(1). 41309–41309. 61 indexed citations

Rincón, Raúl, Sandra Zazo, Cristina Chamizo, et al.. (2016). c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer. Molecular Cancer Therapeutics. 15(11). 2780–2790. 12 indexed citations

Stanisavljević, Jelena, Jordina Loubat‐Casanovas, Mercedes Herrera, et al.. (2014). Snail1-Expressing Fibroblasts in the Tumor Microenvironment Display Mechanical Properties That Support Metastasis. Cancer Research. 75(2). 284–295. 98 indexed citations

10.

Cañadas, Israel, Federico Rojo, Álvaro Taus, et al.. (2013). Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer. Clinical Cancer Research. 20(4). 938–950. 107 indexed citations

11.

Rojo, Federico, Laia Domingo, María Sala, et al.. (2013). Gene Expression Profiling in True Interval Breast Cancer Reveals Overactivation of the mTOR Signaling Pathway. Cancer Epidemiology Biomarkers & Prevention. 23(2). 288–299. 10 indexed citations

12.

Campos, Javier, et al.. (2013). FUTUR: el nou portal de la producció científica de la Universitat Politècnica de Catalunya. 145–156. 2 indexed citations

13.

Inglés‐Esteve, Julia, M.L González Morales, Alba Dalmases, et al.. (2012). Inhibition of Specific NF-κB Activity Contributes to the Tumor Suppressor Function of 14-3-3σ in Breast Cancer. PLoS ONE. 7(5). e38347–e38347. 25 indexed citations

14.

Rovira, Ana, et al.. (2008). Effects of local abundance on pollination and reproduction in the narrow endemic endangered species Delphinium bolosii (Ranunculaceae). LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 23(23). 27–46. 3 indexed citations

15.

Codony‐Servat, Jordi, Marta Bosch, Cristina Oliva, et al.. (2006). Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells. Molecular Cancer Therapeutics. 5(3). 665–675. 88 indexed citations

16.

Blanché, Cèsar, et al.. (1997). Delphinium L. subgen. Delphinium in the iberian peninsula and north Africa: a new taxonomic approach. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 19(1). 59–82. 4 indexed citations

17.

Molero, Julià, et al.. (1996). Euphorbia L. sect. Cymatospermum (Prokh.) Prokh. (Euphorbiaceae) en la Peninsula Iberica. Morfologia de las semillas. Precisiones taxonomicas y corologicas sobre algunos taxones criticos. 25(4). 581–7. 4 indexed citations

18.

Rovira, Ana, et al.. (1988). Notes florístiques i corològiques 1-158. SHILAP Revista de lepidopterología. 17(1). 135–150. 1 indexed citations

19.

Rovira, Ana, et al.. (1985). Peucedanum schottii Besser ex DC., novedad para la flora Iberica. Anales del Jardín Botánico de Madrid. 42(2). 537. 1 indexed citations

20.

Rovira, Ana, et al.. (1984). Noves dades per a la flora vascular de l'Alt Empordà. Butlletí de la Institució Catalana d'Història Natural. 117–121. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact